Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004090
CNY
46.52
-1.11 (-2.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,222.30
5,476.87
11,133.91
5,723.62
2,341.75
1,174.50
974.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,222.30
5,476.87
11,133.91
5,723.62
2,341.75
1,174.50
974.70
Raw Material Cost
1,000.37
1,059.58
1,275.33
883.61
493.02
394.43
332.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
338.27
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.81
8.01
8.43
6.22
2.06
1.38
6.32
Selling and Distribution Expenses
667.95
1,753.98
3,533.93
1,913.75
795.01
460.53
369.79
Other Expenses
77.38
109.37
103.14
65.20
-4.01
15.05
11.93
Total Expenditure (Excl Depreciation)
2,450.91
3,915.24
5,849.05
3,455.62
1,588.28
1,006.87
827.38
Operating Profit (PBDIT) excl Other Income
-228.6
1561.6
5284.9
2268
753.5
167.60000000000002
147.3
Other Income
372.81
274.52
316.38
90.37
39.60
61.94
166.04
Operating Profit (PBDIT)
363.34
1,891.47
5,739.67
2,439.06
850.46
293.34
362.08
Interest
8.81
8.01
8.43
6.22
2.06
1.38
6.32
Exceptional Items
31.20
-234.45
9.98
1.61
0.35
0.20
-4.64
Gross Profit (PBDT)
1,221.94
4,417.30
9,858.58
4,840.00
1,848.73
780.07
642.70
Depreciation
318.24
255.61
158.53
110.31
86.54
82.31
62.92
Profit Before Tax
67.48
1,393.39
5,582.69
2,324.15
762.20
209.85
288.20
Tax
-41.61
146.89
719.39
244.93
82.64
6.51
-2.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
106.24
1,247.68
4,735.80
2,021.47
677.00
208.86
293.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
106.24
1,247.68
4,735.80
2,021.47
677.00
208.86
293.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.86
-1.18
127.51
57.75
4.82
1.44
-0.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
109.09
1,246.50
4,863.30
2,079.21
681.82
210.30
292.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,262.80
12,700.60
12,341.26
4,466.29
2,553.67
1,558.82
1,349.96
Earnings per share (EPS)
0.08
0.99
3.79
1.64
0.55
0.17
0.24
Diluted Earnings per share
0.08
0.99
3.79
1.64
0.55
0.17
0.24
Operating Profit Margin (Excl OI)
-14.75%
24.86%
47.29%
39.11%
30.93%
12.69%
13.66%
Gross Profit Margin
17.36%
30.11%
51.57%
42.53%
36.24%
24.88%
36.02%
PAT Margin
4.78%
22.78%
42.53%
35.32%
28.91%
17.78%
30.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -59.42% vs -50.81% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -91.25% vs -74.37% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -100.59% vs -70.18% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 10.00% vs -4.76% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,222.30
0
2,222.30
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,222.30
0
2,222.30
Raw Material Cost
1,000.37
0
1,000.37
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.81
0
8.81
Selling and Distribution Expenses
667.95
0
667.95
Other Expenses
77.38
0.00
77.38
Total Expenditure (Excl Depreciation)
2,450.91
0
2,450.91
Operating Profit (PBDIT) excl Other Income
-228.61
0.00
-228.61
Other Income
372.81
0
372.81
Operating Profit (PBDIT)
363.34
0
363.34
Interest
8.81
0
8.81
Exceptional Items
31.20
0
31.20
Gross Profit (PBDT)
1,221.94
0
1,221.94
Depreciation
318.24
0
318.24
Profit Before Tax
67.48
0
67.48
Tax
-41.61
0
-41.61
Provisions and contingencies
0
0
0.00
Profit After Tax
106.24
0
106.24
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
106.24
0
106.24
Share in Profit of Associates
0
0
0.00
Minority Interest
2.86
0
2.86
Other related items
0.00
0.00
0.00
Consolidated Net Profit
109.09
0
109.09
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,262.80
0
12,262.80
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
-14.75%
0%
0.00
-14.75%
Gross Profit Margin
17.36%
0%
0.00
17.36%
PAT Margin
4.78%
0%
0.00
4.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 222.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -59.42% vs -50.81% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 10.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -91.25% vs -74.37% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -100.59% vs -70.18% in Dec 2023

Annual - Interest
Interest 0.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.00% vs -4.76% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -14.75%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023